Trials / Unknown
UnknownNCT05635435
Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes
Preoperative Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes: A Prospective Multi-Institutional Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,282 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Our study considered the relevant immune and inflammatory indices, such as immunoglobulin kappa light chain, TNF, and CD4+ Helper T lymphocyte% in a multi-institutional study with a large patient cohort (n=1282) from the east, northeast, and southeast of China. Our study shed light on the association of peripheral immune system status with prognosis, tumor grade, and subtype of glioma, which can potentially benefit future diagnostic and prognostic processes of glioma given its noninvasive nature. Moreover, the preoperative inflammatory status can be leveraged for timely interventions to reverse the immunosuppressive status of cancer patients and enhance anti-tumour immunity of glioma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Detection of Immune and Inflammatory Indices in Peripheral Blood | We detected immune and inflammatory indices in peripheral blood at each patient's at first hospitalizatin from October 13th, 2006, to April 6th, 2022. |
Timeline
- Start date
- 2006-10-13
- Primary completion
- 2022-04-06
- Completion
- 2023-12-20
- First posted
- 2022-12-02
- Last updated
- 2023-07-12
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05635435. Inclusion in this directory is not an endorsement.